HUP0002117A3 - Clear, injectable formulation of an anesthetic compound - Google Patents

Clear, injectable formulation of an anesthetic compound

Info

Publication number
HUP0002117A3
HUP0002117A3 HU0002117A HUP0002117A HUP0002117A3 HU P0002117 A3 HUP0002117 A3 HU P0002117A3 HU 0002117 A HU0002117 A HU 0002117A HU P0002117 A HUP0002117 A HU P0002117A HU P0002117 A3 HUP0002117 A3 HU P0002117A3
Authority
HU
Hungary
Prior art keywords
clear
injectable formulation
anesthetic compound
anesthetic
compound
Prior art date
Application number
HU0002117A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Publication of HUP0002117A2 publication Critical patent/HUP0002117A2/hu
Publication of HUP0002117A3 publication Critical patent/HUP0002117A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0002117A 1997-05-26 1998-05-14 Clear, injectable formulation of an anesthetic compound HUP0002117A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.

Publications (2)

Publication Number Publication Date
HUP0002117A2 HUP0002117A2 (hu) 2000-12-28
HUP0002117A3 true HUP0002117A3 (en) 2001-04-28

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002117A HUP0002117A3 (en) 1997-05-26 1998-05-14 Clear, injectable formulation of an anesthetic compound

Country Status (23)

Country Link
US (1) US6326406B1 (forum.php)
EP (1) EP0991405B1 (forum.php)
JP (1) JP2001527577A (forum.php)
KR (1) KR20010013011A (forum.php)
CN (1) CN1268051A (forum.php)
AR (1) AR012853A1 (forum.php)
AT (1) ATE230984T1 (forum.php)
AU (1) AU735020B2 (forum.php)
BR (1) BR9809492A (forum.php)
CA (1) CA2291261A1 (forum.php)
CH (1) CH692322A5 (forum.php)
DE (1) DE69810771D1 (forum.php)
DZ (1) DZ2503A1 (forum.php)
HU (1) HUP0002117A3 (forum.php)
IN (1) IN187550B (forum.php)
MY (1) MY132911A (forum.php)
NO (1) NO995831L (forum.php)
PA (1) PA8451701A1 (forum.php)
PE (1) PE75299A1 (forum.php)
PL (1) PL337026A1 (forum.php)
TR (1) TR200000116T2 (forum.php)
WO (1) WO1998053805A1 (forum.php)
ZA (1) ZA984314B (forum.php)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
HK1040195B (zh) 1998-08-19 2006-06-02 Skyepharma Canada Inc. 普鲁泊福的可注射水分散体
CN1151782C (zh) * 1999-01-28 2004-06-02 迪内希·尚蒂拉尔·帕特尔 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
EP1585548B1 (en) * 2002-12-09 2018-06-27 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
EP1928435B8 (en) 2005-08-31 2019-03-20 Abraxis BioScience, LLC Compositions of poorly water soluble drugs with increased stability and methods for preparation thereof
ES2718323T3 (es) 2005-08-31 2019-07-01 Abraxis Bioscience Llc Composiciones que comprenden agentes farmacéuticos poco solubles en agua
KR20110083604A (ko) * 2008-11-20 2011-07-20 테이코쿠 팔마 유에스에이, 인코포레이티드 피라졸론 유도체 제제
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
EP3761961A4 (en) * 2018-03-07 2022-01-05 Andrew Xian Chen AQUEOUS FORMULATIONS FOR INSOLUBLE DRUGS
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
GB1472793A (en) 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE3221579A1 (de) 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
AU6708096A (en) * 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
PL337026A1 (en) 2000-07-31
BR9809492A (pt) 2000-06-20
PA8451701A1 (es) 2000-05-24
CH692322A5 (it) 2002-05-15
IN187550B (forum.php) 2002-05-18
CA2291261A1 (en) 1998-12-03
EP0991405B1 (en) 2003-01-15
TR200000116T2 (tr) 2000-05-22
ATE230984T1 (de) 2003-02-15
US6326406B1 (en) 2001-12-04
JP2001527577A (ja) 2001-12-25
WO1998053805A1 (en) 1998-12-03
KR20010013011A (ko) 2001-02-26
MY132911A (en) 2007-10-31
NO995831D0 (no) 1999-11-26
PE75299A1 (es) 1999-08-26
CN1268051A (zh) 2000-09-27
DZ2503A1 (fr) 2005-01-25
AU8209798A (en) 1998-12-30
EP0991405A1 (en) 2000-04-12
AU735020B2 (en) 2001-06-28
DE69810771D1 (de) 2003-02-20
NO995831L (no) 2000-01-26
ZA984314B (en) 1998-12-08
AR012853A1 (es) 2000-11-22
HUP0002117A2 (hu) 2000-12-28

Similar Documents

Publication Publication Date Title
HUP0002117A3 (en) Clear, injectable formulation of an anesthetic compound
AU7389098A (en) Local anesthetic formulations
ZA9878B (en) New formulation for inhalation
AU1306799A (en) Improved injector syringe
ZA9811461B (en) New formulation
EG22250A (en) Novel pharmaceutical compound
EP0976407A4 (en) ANTISEPTIC COMPOSITIONS
GB9812038D0 (en) Therapeutic compound
GB9912446D0 (en) Injectable anesthetic formulation
HUP0004665A3 (en) Anaesthetic formulation
ZA985669B (en) New formulation
EP1121950A4 (en) MEDICATION INJECTOR
IL122920A (en) Castrointestinal drug composition
AU5336598A (en) Reduction of emissions of volatile compounds by additives
GB9700789D0 (en) Syringe
GB9723859D0 (en) Compound,composition and use
IL132784A0 (en) Pharmaceutical compositions containing dronabinol
GB9723856D0 (en) Compound,composition and use
GB9723853D0 (en) Compound, composition and use
GB9820883D0 (en) Syringe
SI1032390T1 (en) Anaesthetic formulation
AUPP117097A0 (en) Injectable compositions
ZA9810587B (en) Anaesthetic formulation.
CA82511S (en) Cannula
GB9721136D0 (en) Syringes